All In Biotech

Drug Trial Radar · NCT00067457

Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy

A 12-Week, Randomized, Double-Blind, Placebo- Controlled Study of PRN BID and Fixed Dosing Regimens of Alosetron in Female Subjects With Severe Diarrhea-Predominant Irritable Bowel Syndrome Who Have Failed Conventional Therapy

Last checked: Nov 19, 2026Latest source record: Apr 16, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 700 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

700

Actual

Start

Jun 2003

Primary completion

Dec 2005

Study completion Dec 2005

Sponsor

Lead sponsor
GlaxoSmithKlineGSK (GSK)
Sponsor type
Industry
First posted
Aug 21, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the safety and effectiveness of as needed versus fixed dosing of an investigational medication for women with severe diarrhea-predominant Irritable Bowel Syndrome (IBS) who have failed conventional therapy.

Conditions

  • Irritable Colon
  • Irritable Bowel Syndrome (IBS)

Interventions

  • alosetronDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Subject self assessment of improvement between treatment groups using the IBS Global Improvement Scale; comparison of safety and tolerability between treatment groups with respect to adverse events & laboratory abnormalities.Time frame: 12 Weeks

Locations

191 sites in 2 countries. Site status is shown where the registry gives one.

  • GSK Investigational Site

    Birmingham, Alabama

  • GSK Investigational Site

    Birmingham, Alabama

  • GSK Investigational Site

    Huntsville, Alabama

  • GSK Investigational Site

    Mobile, Alabama

  • GSK Investigational Site

    Pell City, Alabama

  • GSK Investigational Site

    Tallassee, Alabama

  • GSK Investigational Site

    Tucson, Arizona

  • GSK Investigational Site

    Little Rock, Arkansas

  • GSK Investigational Site

    North Little Rock, Arkansas

  • GSK Investigational Site

    Beverly Hills, California

  • GSK Investigational Site

    Carlsbad, California

  • GSK Investigational Site

    Concord, California

  • GSK Investigational Site

    Encinitas, California

  • GSK Investigational Site

    Fresno, California

  • GSK Investigational Site

    Garden Grove, California

  • GSK Investigational Site

    Los Angeles, California

  • GSK Investigational Site

    Orange, California

  • GSK Investigational Site

    Roseville, California

  • GSK Investigational Site

    San Diego, California

  • GSK Investigational Site

    San Diego, California

  • GSK Investigational Site

    San Diego, California

  • GSK Investigational Site

    San Francisco, California

  • GSK Investigational Site

    San Francisco, California

  • GSK Investigational Site

    San Francisco, California

  • GSK Investigational Site

    Santa Ana, California

  • GSK Investigational Site

    Spring Valley, California

  • GSK Investigational Site

    Torrance, California

  • GSK Investigational Site

    Van Nuys, California

  • GSK Investigational Site

    Centennial, Colorado

  • GSK Investigational Site

    Colorado Springs, Colorado

  • GSK Investigational Site

    Littleton, Colorado

  • GSK Investigational Site

    Longmont, Colorado

  • GSK Investigational Site

    Bristol, Connecticut

  • GSK Investigational Site

    Belleair Bluffs, Florida

  • GSK Investigational Site

    Boca Raton, Florida

  • GSK Investigational Site

    Bradenton, Florida

  • GSK Investigational Site

    Clearwater, Florida

  • GSK Investigational Site

    Clearwater, Florida

  • GSK Investigational Site

    DeLand, Florida

  • GSK Investigational Site

    Gainesville, Florida

Showing 40 of 191 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.